Home › Funds › Private Capital Management, LLC › LGND
Private Capital Management, LLC position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
Private Capital Management, LLC reported holding 124,822 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$39.0M, representing 4.03% of its reported portfolio and ranking #6 among its reported holdings. Private Capital Management, LLC has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Private Capital Management, LLC's LGND position evolved
Private Capital Management, LLC first disclosed a stake in LGND in Q2 2024 at 134,505 shares (US$11.3M). The position peaked in Q2 2026 at 166,016 shares, worth US$52.5M. Across 10 filings, Private Capital Management, LLC increased the stake 2 time(s), trimmed it 5 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 124,822 shares valued at US$39.0M — a reduction of -41,194 shares quarter over quarter.. Notable position changes include a 55% increase in Q2 2025 (shares rose 56% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 134.50K | $11.33M | New |
| Q3 2024 | 133.88K | $13.40M | Hold |
| Q4 2024 | 133.69K | $14.32M | Hold |
| Q1 2025 | 148.12K | $15.54M | Add |
| Q2 2025 | 229.25K | $26.06M | Add |
| Q3 2025 | 227.16K | $40.24M | Reduce |
| Q4 2025 | 208.89K | $39.50M | Reduce |
| Q1 2026 | 201.38K | $40.21M | Reduce |
| Q2 2026 | 166.02K | $52.48M | Reduce |
| Q3 2026 | 124.82K | $38.99M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 223.91K sh · $69.94M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 166.34K sh · $51.96M · Q3 2026
- Granahan Investment Management, LLC 154.32K sh · $48.20M · Q3 2026
- SILVERBACK ASSET MANAGEMENT LLC 25.00M sh · $42.00M · Q3 2026
- TENOR CAPITAL MANAGEMENT Co., L.P. 22.61M sh · $38.08M · Q3 2026
More on Private Capital Management, LLC
FAQ
How long has Private Capital Management, LLC held LGND?
Private Capital Management, LLC has disclosed LGND holdings in 10 of the last 10 reported quarters, going back to Q2 2024.
What is Private Capital Management, LLC's current position in LGND?
As of Q3 2026, Private Capital Management, LLC holds 124.82K shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $38.99M, representing 4.03% of its reported portfolio and ranking #6.
Has Private Capital Management, LLC been buying or selling LGND?
In the latest 13F filing (Q3 2026), Private Capital Management, LLC reduced its position in LGND. The position peaked in Q2 2026 at 166.02K shares.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.